Drexler Karen 4

What Happened
Karen Drexler, a director of Outset Medical, was granted 10,667 restricted stock units (RSUs) on 2026-06-04. The grant is reported as an award (Transaction Code A) at a $0.00 per-share price (aggregate reported value $0). This is a compensation grant, not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-04; Form 4 filed: 2026-06-05 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares/units granted: 10,667 RSUs; reported price: $0.00; aggregate $0.
• Vesting: 100% of the shares underlying these RSUs vest upon the earlier of (i) the one‑year anniversary of the grant or (ii) the date of the issuer’s next Annual Meeting of Stockholders (per footnote).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• No indication of a 10b5-1 plan, tax withholding, or immediate sale in this filing.

Context
RSU grants to directors are common as part of compensation and do not by themselves indicate a buy/sell signal. The shares will only become deliverable if/when the RSUs vest under the stated conditions; future filings may show ownership changes or sales once vesting occurs.